HIV T cell vaccines, the importance of clades

Vaccine

Volumn 20, Issue 15, 2002, Pages 1918-1921

  McMichael, Andrew ^a   Mwau, Matilu ^a   Hanke, Tomás ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

CD8 T cells; HIV clades; HIV vaccines

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY;

ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DRUG DESIGN; DRUG SCREENING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

AIDS VACCINES; AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENIC VARIATION; CLINICAL TRIALS, PHASE I; EPITOPES; HIV; HIV ANTIBODIES; HIV ANTIGENS; HIV INFECTIONS; HLA ANTIGENS; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; INTERLEUKIN-2; KENYA; MACACA; MICE; NEUTRALIZATION TESTS; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VACCINES, SYNTHETIC;

EID: 0037029914     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00067-1     Document Type: Article

References (26)

1. Cellular immune responses to HIV
2. Direct visualisation of HIV-1-specific cytotoxic T lymphocytes during primary infection
3. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
4. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques
5. Escape of human immunodeficiency virus from immune control
6. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses
7. Evolution and transmission of stable CTL escape mutations in HIV infection
8. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function
9. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
10. The transporters associated with antigen presentation
11. Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya
12. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes
13. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
14. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi
15. Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP
16. DNA immunisation: Ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction
17. Effective DNA vaccination against Listeriosis by prime/boost inoculation with the gene gun
18. Control of a mucosal challenge and prevention of aids by a multiprotein DNA/MVA vaccine
19. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
20. Chemistry of peptides associated with MHC class I and class II molecules
21. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
22. Antagonist HIV-1 gag peptides induce structural changes in HLA B8
23. The specificity of recognition of a cytotoxic T lymphocyte epitope
24. Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53
25. Immune control of HIV: The obstacles of HLA and viral diversity
26. Selection of virus variants and emergence of virus escape mutants after immunisation with an epitope vaccine